Ra Medical Systems, Inc.
RMED · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7,593 | $7,668 | $6,488 | $1,877 |
| - Cash | $1,075 | $838 | $450 | $2,873 |
| + Debt | $3,481 | $2,971 | $1,688 | $1,788 |
| Enterprise Value | $9,999 | $9,801 | $7,726 | $792 |
| Revenue | $226 | $212 | $143 | $93 |
| % Growth | 6.6% | 48.3% | 53.8% | – |
| Gross Profit | $208 | $198 | $132 | $87 |
| % Margin | 92% | 93.4% | 92.3% | 93.5% |
| EBITDA | -$1,703 | -$4,672 | -$3,564 | $49,626 |
| % Margin | -753.5% | -2,203.8% | -2,492.3% | 53,360.8% |
| Net Income | -$2,251 | -$5,109 | -$4,045 | $48,902 |
| % Margin | -996% | -2,409.9% | -2,828.7% | 52,582.8% |
| EPS Diluted | -1.7 | -0.38 | -0.36 | 18.54 |
| % Growth | -347.4% | -5.6% | -101.9% | – |
| Operating Cash Flow | -$4,446 | $0 | -$2,338 | $2,639 |
| Capital Expenditures | -$7 | $0 | -$10 | -$30 |
| Free Cash Flow | -$4,453 | $0 | -$2,348 | $2,609 |